Tumor-intrinsic SIRPA promotes sensitivity to checkpoint inhibition immunotherapy in melanoma is a research paper published in Cancer Cell (2022). On theSindex it has a DataRank of 0.584. It has been cited 48 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.584
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →National Institutes of Health
Grant: P30CA016672
National Institutes of Health
Grant: U01CA253472
National Institutes of Health
Grant: U24CA209851
National Cancer Institute
Grant: P50CA221703
National Cancer Institute
Grant: R01CA251150
National Cancer Institute
Grant: R50CA221675
National Cancer Institute
Grant: U01CA217842
National Cancer Institute
Grant: U24CA264128
Cancer Prevention and Research Institute of Texas
Grant: RP170593
Fields of Study
MeSH Terms
Keywords